Virus Testing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Application, By End User, By Region and Competition, 2020-2030F

Description

Global Virus Testing Kits Market has valued at USD 16.57 Billion in 2024 and is expected to reach USD 22.58 Billion by 2030 with a CAGR of 5.29% during the forecast period. The virus test kit is a diagnostic tool used to detect antibodies in infected individuals through various testing methods, including DFA, agglutinating testing, PCR, and solid-stage testing. The virus progressively affects lymphocytes, which play a vital role in the body's immune defense. Advanced technology platforms, such as enzyme-assisted nano complexes for visual identification of nucleic acids, can be designed to detect a wide range of diseases. These kits are instrumental in controlling emerging infectious diseases and high-prevalence infections. They are based on techniques commonly employed in virology laboratories for rapid antigen testing, serology, and molecular diagnostics to detect virus antibodies. According to the World Health Organization (WHO) data, as of February 2022, over 422 million confirmed cases and over 5.8 million deaths have been reported globally. This surge in COVID-19 infections has led to a significant increase in the demand for COVID-19 detection kits globally.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 16.57 Billion
Market Size 2030	USD 22.58 Billion
CAGR 2025-2030	5.29%
Fastest Growing Segment	Hepatitis
Largest Market	North America

Key Market Drivers

Growing Prevalence of Infectious Diseases

The increasing global burden of rare diseases necessitates accurate diagnosis and effective treatment strategies for various chronic conditions. Developing countries such as China, India, Japan, Brazil, and other Southeast Asian nations have witnessed improved diagnosis rates due to heightened awareness of terminal illness symptoms. However, even with technologically advanced diagnostic equipment, a small margin of human error still hinders the process, resulting in a significant number of patients remaining undiagnosed at an early stage and complicating treatment. Influenza epidemics and pandemics have a profound impact on both individuals and populations. For instance, the National Institutes of Health serosurvey includes investigating blood samples of over 10,000 U.S. adults with no confirmed history of coronavirus infection to detect anti-SARS-CoV-2 protein IgM and IgG antibodies. It also includes additional tests to evaluate the immune responses of volunteers to the virus. The burden of influenza varies depending on age and underlying health conditions, with high-risk patients, such as the elderly and those with pre-existing medical conditions, experiencing more frequent hospitalizations and care. As patient populations continue to grow, there is an increasing need to assess the burden of influenza, particularly due to escalating medical costs. However, accurately estimating disease prevalence can be challenging, as influenza is often mistaken for other viral illnesses, leading to under-reporting. In addition to direct costs associated with medical care, such as absenteeism and loss of work efficiency, indirect costs of influenza are substantial. Cost estimates from France, the United States, and Germany have shown that indirect costs can be five to ten times higher than direct costs. Thus, understanding the true burden of influenza is crucial for effective resource allocation and mitigation strategies.

Key Market Challenges

Lack of Awareness Across LMIC (Low- and Middle-Income Countries) Economies

The field of diagnosis distinguishes itself from other sectors of the pharmaceutical industry due to a shorter life cycle for virus diagnostic products and variations in regulatory approval methods. The diagnostic market is experiencing growth, particularly in emerging countries, driven by government initiatives to improve healthcare facilities and an increasing patient population. However, limited accessibility to diagnostic tests in emerging economies remains a challenge compared to developed economies. LMIC economies often have limited access to reliable information due to challenges such as low literacy rates, lack of internet connectivity, and limited healthcare infrastructure. This results in a lack of awareness about the importance of virus testing and the availability of testing kits. Many LMICs face challenges in providing adequate health education to their populations. As a result, individuals may not fully understand the importance of timely testing for infectious diseases.

Lack of healthcare infrastructure, including laboratories and testing facilities, can limit the availability of testing services and hinder awareness campaigns. High healthcare costs and limited access to health insurance can deter individuals from seeking testing, especially when they are not fully aware of its importance. Individuals in LMICs may have competing priorities for their limited resources, such as food, housing, and education. This can lead to healthcare taking a lower priority, including the decision to undergo testing.

Key Market Trends

Emerging Economies to Offer Lucrative Growth Opportunities

Emerging economies like India, Brazil, and China present lucrative opportunities for the private health sector. Multinational companies have established their presence in these countries through partnerships or acquisitions of local diagnostic firms. In developing nations such as India, China, and Brazil, where improving living standards and an aging population drive the demand for chronic disease diagnosis and management, the disease burden is undergoing a transformation. Emerging economies offer immense potential for growth in the private health sector. The rising middle class, increased urbanization, and growing disposable incomes are driving higher demand for quality healthcare services, including diagnostics, treatments, and management of chronic diseases. Many multinational healthcare companies recognize the opportunities in these markets and are establishing their presence through strategic partnerships, collaborations, acquisitions, or investments in local diagnostic firms. This allows them to leverage local expertise and infrastructure while expanding their global footprint. Collaborating with or acquiring local diagnostic firms provides multinational companies with an understanding of local market dynamics, regulatory frameworks, and patient needs. This enables them to tailor their offerings effectively and navigate regulatory challenges. These factors collectively contribute to the promising growth prospects for manufacturers of virus diagnostic kits.

Key Market Players

Qiagen N.V.
Abbott Laboratories Inc
Thermo Fisher Scientific Inc
Becton, Dickinson and Company
BioMerieux SA
Quidel Corporation
Rapikit
Zoetis Inc
Luminex Corporation
F. Hoffmann-La Roche Ltd

Report Scope:

In this report, the Global Virus Testing Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virus Testing Kits Market, By Test Type:

DFA Tests
Lateral Flow Tests
RT-PCR
Agglutination Assays
Solid-Phase Assays
Others

Virus Testing Kits Market, By Application:

Influenza
Hepatitis
HIV
Measles/Rubella
Rotavirus
Others

Virus Testing Kits Market, By End User:

Hospitals & Clinics
Diagnostic Centres & Laboratories
Academic & Research Institutions
Others

Virus Testing Kits Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Available Customizations:

Global Virus Testing Kits market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virus Testing Kits Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Test Type (DFA Tests, Lateral Flow Tests, RT-PCR, Agglutination Assays, Solid-Phase Assays, Others)
- 5.2.2. By Application (Influenza, Hepatitis, HIV, Measles/Rubella, Rotavirus, Others)
- 5.2.3. By End User (Hospitals & Clinics, Diagnostic Centres & Laboratories, Academic & Research Institutions, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Virus Testing Kits Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Test Type
- 6.2.2. By Application
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Virus Testing Kits Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Test Type
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By End User
- 6.3.2. Canada Virus Testing Kits Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Test Type
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By End User
- 6.3.3. Mexico Virus Testing Kits Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Test Type
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By End User

7. Europe Virus Testing Kits Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Test Type
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Virus Testing Kits Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Test Type
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End User
- 7.3.2. United Kingdom Virus Testing Kits Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Test Type
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End User
- 7.3.3. Italy Virus Testing Kits Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Test Type
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End User
- 7.3.4. France Virus Testing Kits Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Test Type
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Virus Testing Kits Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Test Type
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By End User

8. Asia-Pacific Virus Testing Kits Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Test Type
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Virus Testing Kits Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Test Type
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End User
- 8.3.2. India Virus Testing Kits Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Test Type
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End User
- 8.3.3. Japan Virus Testing Kits Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Test Type
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End User
- 8.3.4. South Korea Virus Testing Kits Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Test Type
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Virus Testing Kits Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Test Type
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End User

9. South America Virus Testing Kits Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Test Type
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Virus Testing Kits Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Test Type
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End User
- 9.3.2. Argentina Virus Testing Kits Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Test Type
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End User
- 9.3.3. Colombia Virus Testing Kits Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Test Type
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End User

10. Middle East and Africa Virus Testing Kits Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Test Type
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Virus Testing Kits Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Test Type
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Virus Testing Kits Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Test Type
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End User
- 10.3.3. UAE Virus Testing Kits Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Test Type
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Virus Testing Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Qiagen N.V.
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Abbott Laboratories Inc
15.3. Thermo Fisher Scientific Inc
15.4. Becton, Dickinson and Company
15.5. BioMerieux SA
15.6. Quidel Corporation
15.7. Rapikit
15.8. Zoetis Inc
15.9. Luminex Corporation
15.10. F. Hoffmann-La Roche Ltd